Relationships between emerging measures of heart failure processes of care and clinical outcomes
- PMID: 20211302
- PMCID: PMC3715106
- DOI: 10.1016/j.ahj.2009.12.024
Relationships between emerging measures of heart failure processes of care and clinical outcomes
Abstract
Background: Previous studies have not confirmed associations between some current performance measures for inpatient heart failure processes of care and postdischarge outcomes. It is unknown if alternative measures are associated with outcomes.
Methods: Using data for 20,441 Medicare beneficiaries in OPTIMIZE-HF from March 2003 through December 2004, which we linked to Medicare claims data, we examined associations between hospital-level processes of care and patient outcomes. Performance measures included any beta-blocker for patients with left ventricular systolic dysfunction (LVSD); evidence-based beta-blocker for patients with LVSD; warfarin for patients with atrial fibrillation; aldosterone antagonist for patients with LVSD; implantable cardioverter-defibrillator for patients with ejection fraction < or =35%; and referral to disease management. Outcome measures were unadjusted and adjusted associations of each process measure with 60-day and 1-year mortality and cardiovascular readmission at the hospital level.
Results: Adjusted hazard ratios for 1-year mortality with a 10% increase in hospital- level adherence were 0.94 for any beta-blocker (95% CI, 0.90-0.98; P = .004), 0.95 for evidence-based beta-blocker (95% CI, 0.92-0.98; P = .004); 0.97 for warfarin (95% CI, 0.92-1.03; P = .33); 0.94 for aldosterone antagonists (95% CI, 0.91-0.98; P = .006); 0.92 for implantable cardioverter-defibrillator (95% CI, 0.87-0.98; P = .007); and 1.01 for referral to disease management (95% CI, 0.99-1.03; P = .21).
Conclusions: Several evidence-based processes of care are associated with improved outcomes, can discriminate hospital-level quality of care, and could be considered as clinical performance measures.
Trial registration: ClinicalTrials.gov NCT00344513.
Figures
Similar articles
-
Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.Am J Med. 2020 Oct;133(10):1187-1194. doi: 10.1016/j.amjmed.2020.02.040. Epub 2020 Apr 6. Am J Med. 2020. PMID: 32272101 Free PMC article.
-
Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).Am Heart J. 2007 Jan;153(1):82.e1-11. doi: 10.1016/j.ahj.2006.10.008. Am Heart J. 2007. PMID: 17174643
-
Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims.Clin Cardiol. 2012 Nov;35(11):649-57. doi: 10.1002/clc.22064. Epub 2012 Oct 15. Clin Cardiol. 2012. PMID: 23070696 Free PMC article.
-
Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis.JACC Heart Fail. 2013 Feb;1(1):21-8. doi: 10.1016/j.jchf.2012.09.002. Epub 2013 Feb 4. JACC Heart Fail. 2013. PMID: 24621795 Review.
-
Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: how much is too much?Curr Heart Fail Rep. 2009 Jun;6(2):112-6. doi: 10.1007/s11897-009-0017-5. Curr Heart Fail Rep. 2009. PMID: 19486595 Review.
Cited by
-
Treatment Strategies of Improving Quality of Care in Patients With Heart Failure.Korean Circ J. 2023 May;53(5):294-312. doi: 10.4070/kcj.2023.0024. Korean Circ J. 2023. PMID: 37161744 Free PMC article. Review.
-
Association between heart failure quality of care and mortality: a population-based cohort study using nationwide registries.Eur J Heart Fail. 2022 Nov;24(11):2066-2077. doi: 10.1002/ejhf.2725. Epub 2022 Nov 9. Eur J Heart Fail. 2022. PMID: 36303264 Free PMC article.
-
Predicted quality benefits of achievable performance benchmarks of chronic heart failure care in China: results from a nationwide observational study.BMJ Open. 2020 Sep 23;10(9):e036786. doi: 10.1136/bmjopen-2020-036786. BMJ Open. 2020. PMID: 32967875 Free PMC article.
-
Mineralocorticoid receptor antagonist use after hospitalization of patients with heart failure and post-discharge outcomes: a single-center retrospective cohort study.BMC Cardiovasc Disord. 2019 Aug 9;19(1):194. doi: 10.1186/s12872-019-1175-3. BMC Cardiovasc Disord. 2019. PMID: 31399059 Free PMC article.
-
Quality Measures in Heart Failure: the Past, the Present, and the Future.Curr Heart Fail Rep. 2019 Feb;16(1):1-6. doi: 10.1007/s11897-019-0417-0. Curr Heart Fail Rep. 2019. PMID: 30712145 Review.
References
-
- Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418–28. - PubMed
-
- Fonarow GC, Yancy CW, Heywood JT. Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry. Arch Intern Med. 2005;165:1469–77. - PubMed
-
- Krumholz HM, Normand SL. Public reporting of 30-day mortality for patients hospitalized with acute myocardial infarction and heart failure. Circulation. 2008;118:1394–7. - PubMed
-
- Rosenthal MB, Landon BE, Normand SL, Frank RG, Epstein AM. Pay for performance in commercial HMOs. N Engl J Med. 2006;355:1895–1902. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
